Altimmune Inc

$ALT is now live. CA: 0x515DF964A0c38255316d0b1e2d632cdAfdf465b1 Altimmune is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. Building next-gen therapies for serious liver diseases. Focused on MASH, AUD, and ALD.

Alcohol use disorder and liver disease are closely connected, though long‑term implications are often overlooked. Closing the knowledge gap requires education, earlier clinical conversations and sustained research, so progress reaches people living with serious liver conditions.